SciLifeLab
Browse
1/1
15 files

A phenomics approach for antiviral drug discovery - Images, analysis pipelines and feature data

dataset
posted on 2021-03-22, 16:09 authored by Jonne RietdijkJonne Rietdijk, Marianna Tampere, Aleksandra Pettke, Polina Georgieva, Maris LapinsMaris Lapins, Ulrika Warpman Berglund, Ola SpjuthOla Spjuth, Marjo-Riitta Puumalainen, Jordi Carreras Puigvert
Abstract:

The current COVID-19 pandemic has highlighted the need for new and fast methods to identify novel or repurposed therapeutic drugs. Here we present a method for untargeted phenotypic drug screening of virus-infected cells, combining Cell Painting with antibody-based detection of viral infection in a single assay. We designed an image analysis pipeline for segmentation and classification of virus-infected and non-infected cells, followed by extraction of morphological properties. We show that the methodology can successfully capture virus-induced phenotypic signatures of MRC-5 human lung fibroblasts infected with Human coronavirus 229E (CoV-229E). Moreover, we demonstrate that our method can be used in phenotypic drug screening using a panel of nine host- and virus-targeting antivirals. Treatment with effective antiviral compounds reversed the morphological profile of the host cells towards a non-infected state. The method can be used in drug discovery for morphological profiling of novel antiviral compounds on both infected and non-infected cells.

Screen description:

The images are of MRC-5 human lung fibroblasts infected with Human coronavirus 229E (CoV-229E) and treated with a panel of nine host- and virus-targeting antivirals. Cells are labelled with five labels that characterise seven cellular components (from the "Cell Painting" assay) as well as with a Coronavirus pan monoclonal antibody combined with a secondary antibody. This experiment consists of 5 plates. Each plate has 60 wells, and 9 fields of view per well. Each field was imaged in five channels (detection wavelengths), and each channel is stored as a separate, grayscale image file in TIFF format.
The channel names (w1-w5) correspond to the following stains: w1 = Hoechst 33342 (HOECHST); w2= Coronavirus pan Monoclonal Antibody (FIPV3-70) + Goat Anti-Mouse IgG H&L secondary antibody (MITO); w3= Wheat Germ Agglutinin/Alexa Fluor 555 + Phalloidin/Alexa Fluor 568 (PHAandWGA); w4= SYTO 14 green (SYTO); w5= Concanavalin A/Alexa Fluor 488 (CONC)

Organization of files:

1) Raw image data:

- MRC5_HCoV229_Plate1.tar.gz
- MRC5_HCoV229_Plate2.tar.gz
- MRC5_Plate3.tar.gz
- MRC5_Plate4.tar.gz
- MRC5_HCoV229_Plate5.tar.gz

2) Image analysis pipelines (CellProfiler 4.0.7):

Cell Profiler project with a subset of images to try out the analysis pipeline:
- Example_PipelineAndData.tar.gz

Quality control, illumination correction and feature extraction pipelines:
- AnalysisPipelines.tar.gz


3) Extracted feature data:

- features_MRC5_HCoV229_Plate1.tar.gz
- features_MRC5_HCoV229_Plate2.tar.gz
- features_MRC5_Plate3.tar.gz
- features_MRC5_Plate4.tar.gz
- features_MRC5_HCoV229_Plate5.tar.gz

Metadata:

The file “Metadata_MRC5_HCoV229E_plate1-5.csv“ contains the metadata in CSV format, with the following fields:
- Plate_id: corresponds to the experimental plate
- Well: well allocation in the 96-well plate
- virus: "virus +" when cells are exposed to virus, and "virus -' for non-infected controls
- Compound: name of compound
- Dose [μM]: dose of compound

For full information, see the manuscript to which this data is linked.

Funding

This project received funding within the SciLifeLab National COVID-19 Research Program and Knut och Alice Wallenbergs stiftelse (KAW 2020.0182). This project also received funding from the Swedish Research Council (2017-05631 for M-R.P; 2020-03731 for OS and JCP), FORMAS (2018-00924 for OS and JR) and the European Union’s Horizon 2020 research and innovation programme under the Marie Skłodowska-Curie grant agreement no 722729. M.T. was supported by SSF (FID15-0010). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.

History

Publisher

Uppsala University

Usage metrics

    Pharmb.io

    Licence

    Exports

    RefWorks
    BibTeX
    Ref. manager
    Endnote
    DataCite
    NLM
    DC